Relationship Between High-risk Alcohol Consumption and Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Seroconversion: a Prospective Sero-epidemiological Cohort Study Among American College Students
Overview
Affiliations
Aims: To estimate the associations between high-risk alcohol consumption and (1) severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) seroconversion, (2) self-reported new SARS-CoV-2 infection and (3) symptomatic COVID-19.
Design: Prospective cohort study.
Setting: Indiana University Bloomington (IUB), IN, USA.
Participants: A total of 1027 IUB undergraduate students (64% female), aged 18 years or older, residing in Monroe County, Indiana, seronegative for SARS-CoV-2 at study baseline.
Measurements: Primary exposure was high-risk alcohol consumption measured with an Alcohol Use Disorders Identification Test (AUDIT) questionnaire score of 8 or more. Primary outcome was SARS-CoV-2 seroconversion since baseline, assessed with two SARS-CoV-2 antibody tests, at baseline (September 2020) and end-line (November 2020). Secondary outcomes were (a) self-reported new SARS-CoV-2 infection at the study end-line and (b) self-reported symptomatic COVID-19 at baseline.
Findings: Prevalence of high-risk alcohol consumption was 32 %. In models adjusted for demographics, students with high-risk alcohol consumption status had 2.44 [95% confidence interval (CI) = 1.35, 4.25] times the risk of SARS-CoV-2 seroconversion and 1.84 (95% CI = 1.04, 3.28) times the risk of self-reporting a positive SARS-CoV-2 infection, compared with students with no such risk. We did not identify any association between high-risk alcohol consumption and symptomatic COVID-19 (prevalence ratio = 1.17, 95% CI = 0.93, 1.47). Findings from sensitivity analyses corroborated these results and suggested potential for a dose-response relationship.
Conclusions: Among American college students, high-risk alcohol consumption appears to be associated with higher risk for severe acute respiratory syndrome coronavirus 2 seroconversion/infection.
Impact of the COVID-19 pandemic on violence exposure and alcohol use among adults who drink alcohol.
Gyamerah A, Dunham A, Ikeda J, Canizares A, McFarland W, Wilson E PLoS One. 2024; 19(12):e0316096.
PMID: 39739971 PMC: 11687906. DOI: 10.1371/journal.pone.0316096.
Cannabis, Tobacco Use, and COVID-19 Outcomes.
Griffith N, Baker T, Heiden B, Smock N, Pham G, Chen J JAMA Netw Open. 2024; 7(6):e2417977.
PMID: 38904961 PMC: 11193123. DOI: 10.1001/jamanetworkopen.2024.17977.
Substances of abuse and their effect on SAR-CoV-2 pathogenesis.
Antwi I, Watkins D, Pedawi A, Ghrayeb A, Van de Vuurst C, Cory T NeuroImmune Pharm Ther. 2023; 2(3):301-316.
PMID: 38013836 PMC: 10474379. DOI: 10.1515/nipt-2023-0004.
Gajda M, Szemik S, Kowalska M Int J Occup Med Environ Health. 2023; 36(3):406-416.
PMID: 37681428 PMC: 10663994. DOI: 10.13075/ijomeh.1896.02158.
Chilunga F, Campman S, Galenkamp H, Boyd A, Bolijn R, Leenstra T Int J Equity Health. 2023; 22(1):127.
PMID: 37403097 PMC: 10320885. DOI: 10.1186/s12939-023-01936-0.